Richard C. Harvey

14.6k citations

48 papers · 2.3k indexed · h-index 20

Public Health, Environmental and Occupational Health top 1%
Hematology top 0.5%
Molecular Biology top 10%
Oncology top 5%
Pediatrics, Perinatology and Child Health top 2%

Co-authors: Stephen P. Hunger Cheryl L. Willman I‐Ming Chen Sarah K. Tasian Charles G. Mullighan O.O. Melnyk John B. Faust T C Meeker
Topics: Acute Lymphoblastic Leukemia research (38 papers)Chronic Myeloid Leukemia Treatments (21 papers)Chronic Lymphocytic Leukemia Research (11 papers)
Cited by: Hematology Public Health, Environmental and Occupational Health Genetics
Journals: Science Proceedings of the National Academy of Sciences Journal of Clinical Oncology
Partner nations: United States Canada United Kingdom

In The Last Decade

Richard C. Harvey

48 papers receiving 2.3k citations

Peers

Countries citing papers authored by Richard C. Harvey

Since Specialization

Citations

This map shows the geographic impact of Richard C. Harvey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard C. Harvey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard C. Harvey more than expected).

Fields of papers citing papers by Richard C. Harvey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard C. Harvey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard C. Harvey. The network helps show where Richard C. Harvey may publish in the future.

Co-authorship network of co-authors of Richard C. Harvey

This figure shows the co-authorship network connecting the top 25 collaborators of Richard C. Harvey. A scholar is included among the top collaborators of Richard C. Harvey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard C. Harvey. Richard C. Harvey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Addition of Inotuzumab to a Pediatric Inspired Chemotherapy Regimen in Young Adult Patients with B-Cell Acute Lymphoblastic Leukemia: Findings from the Alliance A041501 Phase 3 Randomized Trial 2024 ·Blood ·Daniel J. DeAngelo,Jun Yin,Anjali S. Advani,Selina M. Luger,(unknown),Michaela Liedtke,Geoffrey L. Uy,Shira Dinner,Lindsay Wilde,Marlise R. Luskin,Caner Saygin,(unknown),Noreen Fulton,Richard C. Harvey,(unknown),Rebecca Teske,Harry P. Erba,Mark R. Litzow,Richard M. Stone,Wendy Stock	5
2	Clinical efficacy of ruxolitinib and chemotherapy in a child with Philadelphia chromosome-like acute lymphoblastic leukemia with GOLGA5-JAK2 fusion and induction failure 2018 ·Haematologica ·Yangyang Ding,(unknown),(unknown),Gerald Wertheim,Fumin Lin,Fengqi Chang,Zhaohui Gu,Charles G. Mullighan,Yong Li,Richard C. Harvey,I‐Ming Chen,Cheryl L. Willman,Stephen P. Hunger,(unknown),Sarah K. Tasian	46
3	Potent efficacy of combined PI3K/mTOR and JAK or ABL inhibition in murine xenograft models of Ph-like acute lymphoblastic leukemia 2016 ·Blood ·Sarah K. Tasian,David T. Teachey,Yong Li,Feng Shen,Richard C. Harvey,I‐Ming Chen,Theresa Ryan,Tiffaney L. Vincent,Cheryl L. Willman,Alexander E. Perl,Stephen P. Hunger,Mignon L. Loh,Martin Carroll,Stephan A. Grupp	110
4	High incidence of Philadelphia chromosome-like acute lymphoblastic leukemia in older adults with B-ALL 2016 ·Leukemia ·Sarah K. Tasian,Christian Hurtz,Gerald Wertheim,Nathanael G. Bailey,Megan S. Lim,Richard C. Harvey,(unknown),Cheryl L. Willman,(unknown),Alexis Zebrowski,Shalini C. Reshmi,Min Li,Noelle V. Frey,Selina M. Luger,Martin Carroll,Alexander E. Perl	58
5	The Frequency and Outcome of Ph-like ALL Associated Abnormalities in Childhood Acute Lymphoblastic Leukaemia Treated on MRC UKALL2003 2016 ·Blood ·Claire Schwab,Amir Enshaei,Kathryn G. Roberts,Lisa J. Russell,Richard C. Harvey,I-Ming L. Chen,Cheryl L. Willman,Charles G. Mullighan,Ajay Vora,Anthony V. Moorman,Christine J. Harrison	5
6	RasGRP1 overexpression in T-ALL increases basal nucleotide exchange on Ras rendering the Ras/PI3K/Akt pathway responsive to protumorigenic cytokines 2015 ·Oncogene ·(unknown),(unknown),(unknown),Milou Tenhagen,Jeroen Bakker,Richard C. Harvey,Stuart S. Winter,Ignacio Rubio,Jeroen P. Roose	35
7	Abstract PR02: Investigating the use of tyrosine kinase inhibitors in Ph-like ALL. 2015 ·Clinical Cancer Research ·Kathryn G. Roberts,Yung‐Li Yang,Debbie Payne-Turner,Richard C. Harvey,I‐Ming Chen,Julie M. Gastier‐Foster,Mignon L. Loh,Cheryl L. Willman,Stephen P. Hunger,Charles G. Mullighan	1
8	Potent Efficacy of Combined PI3K/mTOR and JAK or SRC/ABL Inhibition in Philadelphia Chromosome-like Acute Lymphoblastic Leukemia 2015 ·Blood ·Sarah K. Tasian,Yong Li,Feng Shen,Theresa Ryan,Tiffaney L. Vincent,David T. Teachey,Shannon L. Maude,Richard C. Harvey,I-Ming L. Chen,Cheryl L. Willman,Alexander E. Perl,Stephen P. Hunger,Mignon L. Loh,Martin Carroll,Stephan A. Grupp	2
9	Evaluation of the In Vitro and In Vivo Efficacy of the JAK Inhibitor AZD1480 against JAK-Mutated Acute Lymphoblastic Leukemia 2014 ·Molecular Cancer Therapeutics ·Santi Suryani,(unknown),Richard C. Harvey,(unknown),Hernán Carol,I‐Ming Chen,Kathryn Evans,(unknown),Kathryn G. Roberts,Raushan T. Kurmasheva,Catherine A. Billups,Charles G. Mullighan,Cheryl L. Willman,Mignon L. Loh,Stephen P. Hunger,Peter J. Houghton,Malcolm A. Smith,Richard B. Lock	43
10	Dysregulated RasGRP1 Responds to Cytokine Receptor Input in T Cell Leukemogenesis 2012 ·DSpace@MIT (Massachusetts Institute of Technology) ·Ming Yang,Christopher C. Govern,Arup K. Chakraborty,(unknown),(unknown),Ed Lemmens,Kristen M. Coakley,Monique Dail,Richard C. Harvey,Jeroen Bakker,Tineke L. Lenstra,(unknown),(unknown),Stuart S. Winter,Mignon L. Loh,Kevin Shannon,Matthias Wabl,Jeroen P. Roose	39
11	Targeting JAK1/2 and mTOR in murine xenograft models of Ph-like acute lymphoblastic leukemia 2012 ·Blood ·Shannon L. Maude,Sarah K. Tasian,Tiffaney L. Vincent,Junior Hall,Cecilia Sheen,Kathryn G. Roberts,Alix E. Seif,David M. Barrett,I‐Ming Chen,Julie Collins,Charles G. Mullighan,Stephen P. Hunger,Richard C. Harvey,Cheryl L. Willman,Jordan S. Fridman,Mignon L. Loh,Stephan A. Grupp,David T. Teachey	196
12	GSI-I (Z-LLNle-CHO) inhibits γ-secretase and the proteosome to trigger cell death in precursor-B acute lymphoblastic leukemia 2011 ·Leukemia ·Xiangbing Meng,Ksenia Matlawska‐Wasowska,François Girodon,Tomáš Mazel,Cheryl L. Willman,Susan J. Atlas,(unknown),Richard C. Harvey,Stephen P. Hunger,Scott A. Ness,Stuart S. Winter,Bridget S. Wilson	32
13	Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia 2010 ·Blood ·Richard C. Harvey,Charles G. Mullighan,I‐Ming Chen,Walker Wharton,Fady M. Mikhail,Andrew J. Carroll,Huining Kang,Wei Liu,Kevin K. Dobbin,Malcolm A. Smith,William L. Carroll,Meenakshi Devidas,W. Paul Bowman,Bruce M. Camitta,Gregory H. Reaman,Stephen P. Hunger,James R. Downing,Cheryl L. Willman	395
14	Lack of Somatic Sequence Mutations In Protein Tyrosine Kinase Genes Other Than the JAK Kinase Family In High Risk B-Precursor Childhood Acute Lymphoblastic Leukemia (ALL): A Report From the Children's Oncology Group (COG) High-Risk (HR) ALL TARGET Project 2010 ·Blood ·Jinghui Zhang,Charles G. Mullighan,Richard C. Harvey,William L. Carroll,I-Ming L. Chen,Meenakshi Devidas,Eric Larsen,Michael N. Edmonson,Ken H. Buetow,Daniela S. Gerhard,Mignon L. Loh,Gregory H. Reaman,Mary V. Relling,Malcolm A. Smith,James R. Downing,Cheryl L. Willman,Stephen P. Hunger	4
15	Correlation between asparaginase sensitivity and asparagine synthetase protein content, but not mRNA, in acute lymphoblastic leukemia cell lines 2007 ·Pediatric Blood & Cancer ·Nan Su,Yuan‐Xiang Pan,Mi Zhou,Richard C. Harvey,Stephen P. Hunger,Michael S. Kilberg	73
16	Two Distinct Subsets of dic(9;12)(p12;p11.2) among Children with B-Cell Precursor Acute Lymphoblastic Leukemia (ALL): PAX5-ETV6 and ETV6-RUNX1 Rearrangements: A Report from the Children’s Oncology Group. 2007 ·Blood ·Julie M. Gastier‐Foster,Andrew J. Carroll,(unknown),Richard C. Harvey,I‐Ming Chen,Rhett P. Ketterling,Aurelia Meloni‐Ehrig,Kent E. Opheim,Shivanand R. Patil,Mark J. Pettenati,Kathleen Rao,Shiqi Wu,Nyla A. Heerema	3
17	Minimal Residual Disease (MRD) and Risk of Relapse in Acute Promyelocytic Leukemia (APL): Insights from the North American Intergroup Phase III Trial C9710. 2006 ·Blood ·Wendy Stock,Richard C. Harvey,Barry Kurt Moser,Dorie Sher,(unknown),Matthew Myers,James L. Slack,Bayard L. Powell,Clara D. Bloomfield,Richard A. Larson,Martin S. Tallman,Frederick R. Appelbaum,James H. Feusner,Cheryl L. Willman,Robert E. Gallagher	2
18	A Gene Expression Classifier for Improved Risk Classification and Outcome Prediction in Pediatric Acute Lymphoblastic Leukemia (ALL). 2005 ·Blood ·Cheryl L. Willman,Huining Kang,Jeffrey Potter,Richard C. Harvey,Susan R. Atlas,(unknown),Paul Helman,Robert Veroff,(unknown),Andrew J. Carroll,Kerem Ar,Yuexian Xu,Sharon B. Murphy,Deepa Bhojwani,(unknown),William L. Carroll,Bruce M. Camitta	3
19	An attempt to eradicate Herpesvirus simiae from a rhesus monkey breeding colony. 1992 ·PubMed ·(unknown),(unknown),Richard C. Harvey,(unknown)	8
20	Characterization of a candidate bcl-1 gene. 1991 ·Molecular and Cellular Biology ·D A Withers,Richard C. Harvey,John B. Faust,O.O. Melnyk,Kate A. Carey,T C Meeker	291

About Richard C. Harvey

Richard C. Harvey is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Genetics, having authored 48 papers that have together received 2.3k indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (38 papers), Chronic Myeloid Leukemia Treatments (21 papers) and Chronic Lymphocytic Leukemia Research (11 papers). The work is most often cited by research in Hematology (1.1k citations), Public Health, Environmental and Occupational Health (1.3k citations) and Genetics (325 citations). Richard C. Harvey has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Stephen P. Hunger, Cheryl L. Willman, I‐Ming Chen, Sarah K. Tasian, Charles G. Mullighan, O.O. Melnyk, John B. Faust, T C Meeker, Kate A. Carey and D A Withers. Their work appears in journals such as Science, Proceedings of the National Academy of Sciences and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact